Search

Your search keyword '"HemispheRx BioPharma Inc. -- Product development"' showing total 3 results
Start Over Descriptor "HemispheRx BioPharma Inc. -- Product development" Publisher ahc media llc
3 results on '"HemispheRx BioPharma Inc. -- Product development"'

1. Hemispherx gears up for NDA with Ampligen data

Subjects
HemispheRx BioPharma Inc. -- Planning, HemispheRx BioPharma Inc. -- Product development, Pharmaceutical industry -- Planning, Pharmaceutical industry -- Product development, Company business planning, Biotechnology industry
Abstract

With hopes of soon filing a new drug application for Ampligen, Hemispherx Biopharma Inc. presented new Phase III data that support the drug's use in chronic fatigue syndrome. At the [...]

Published
2004

2. Laboratories Del Dr. Esteve SA, of Barcelona, Spain, received import authorization for Ampligen, which is partnered with Hemispherx Biopharma Inc., of Philadelphia, to conduct a clinical trial in patients coinfected with hepatitis C and HIV viruses

Subjects
HemispheRx BioPharma Inc. -- Product development, HIV (Viruses), Clinical trials, Hepatitis C, Comorbidity, Biotechnology industry, Business, Business, international
Abstract

* Laboratories Del Dr. Esteve SA, of Barcelona, Spain, received import authorization for Ampligen, which is partnered with Hemispherx Biopharma Inc., of Philadelphia, to conduct a clinical trial in patients [...]

Published
2004

3. Hemispherx's Ampligen hits endpoint in CFS

Subjects
HemispheRx BioPharma Inc. -- Product development, Chronic fatigue syndrome -- Care and treatment, Biotechnology industry -- Product development, Biotechnology industry
Abstract

Hemispherx Biopharma Inc. a-chieved its primary endpoint in a pivotal Phase III trial of Ampligen to treat chronic fatigue syndrome (CFS), giving the Philadelphia-based company the data it needs to [...]

Published
2004

Catalog

Books, media, physical & digital resources
See catalog results